Raphael Reinbold

Raphael Reinbold

Auto-generated profile, based on publicly available information

Raphael Reinbold

Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
RRRaphael Reinbold
Raphael Reinbold
IHIngvild C. Hvinden
Ingvild C. Hvinden
PRPatrick Rabe
Patrick Rabe
RHRyan A. Herold
Ryan A. Herold
AFAlina Finch
Alina Finch
CSChristopher J. Schofield
Christopher J. Schofield
Ivosidenib, an inhibitor of isocitrate dehydrogenase 1 (IDH1) R132C and R132H variants, is approved for the treatment of acute myeloid leukaemia (AML). Resistance to ivosidenib due to a second site mutation of IDH1 R132C, leading to IDH1 R132C/S280F, has emerged. We describe biochemical, crystallographic, and cellular studies on the IDH1 R132C/S280F and R132H/S280F variants that inform on the mechanism of second-site resistance, which involves both modulation of inhibitor binding at the IDH1 dimer-interface and alteration of kinetic properties, which enable more efficient 2-HG production relative to IDH1 R132C and IDH1 R132H. Importantly, the biochemical and cellular results demonstrate that it should be possible to overcome S280F mediated resistance in AML patients by using alternative inhibitors, including some presently in phase 2 clinical trials.

4 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RRRaphael Reinbold
Raphael Reinbold
TJTobias John
Tobias John
PSPaolo Spingardi
Paolo Spingardi
AKAkane Kawamura
Akane Kawamura
ATAmber L. Thompson
Amber L. Thompson
RHRichard J. Hopkinson
Richard J. Hopkinson
Formaldehyde (HCHO) is a simple and highly reactive human metabolite but its biochemistry is poorly defined. A limiting factor in HCHO research is lack of validated quantification methods for HCHO relevant to biological samples. We describe spectroscopic studies on a reported fluorescence-based HCHO detection method involving its reaction with ampicillin. The results validate the structure and fluorescence properties of the HCHO-ampicillin reaction product. However, the same adduct is observed after reaction of ampicillin with glyoxylate. Related fluorophores were formed with other biologically relevant carbonyl compounds. Overall, our studies suggest the ampicillin method is not reliable for selective detection and quantification of HCHO in biological samples.

21 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RRRaphael Reinbold
Raphael Reinbold
TJTobias John
Tobias John
PSPaolo Spingardi
Paolo Spingardi
AKAkane Kawamura
Akane Kawamura
CSChristopher J. Schofield
Christopher J. Schofield
RHRichard J. Hopkinson
Richard J. Hopkinson
Metampicillin is a β-lactam antibiotic that is prepared by the reaction of ampicillin with formaldehyde. Although metampicillin has been studied for treatment of infections in animals and humans, its structure has been unclear. We report NMR studies revealing that metampicillin contains a formaldehyde-derived cyclic aminal. NMR time-course experiments with excess formaldehyde in solution show formation of another product with an additional exocyclic hemiaminal group formed by reaction with the cyclic aminal nitrogen. The exocyclic hemiaminal group is readily removed by reaction with the formaldehyde scavenger 1,3-cyclohexanedione, whereas the cyclic aminal methylene exhibits greater stability. The overall results assign the structure of metampicillin as containing a cyclic aminal and further reveal the potential for complexity in the reaction of formaldehyde with biomedicinally relevant molecules.